U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.-39-332G>T AND Breast-ovarian cancer, familial, susceptibility to, 2

Germline classification:
Benign (1 submission)
Last evaluated:
Jan 12, 2015
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000191549.1

Allele description [Variation Report for NM_000059.4(BRCA2):c.-39-332G>T]

NM_000059.4(BRCA2):c.-39-332G>T

Genes:
LOC130009523:ATAC-STARR-seq lymphoblastoid active region 7554 [Gene]
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.-39-332G>T
Other names:
IVS 1-332G>T
HGVS:
  • NC_000013.11:g.32316090G>T
  • NG_012772.3:g.5611G>T
  • NG_017006.2:g.4274C>A
  • NM_000059.4:c.-39-332G>TMANE SELECT
  • LRG_293t1:c.-39-332G>T
  • LRG_293:g.5611G>T
  • NC_000013.10:g.32890227G>T
  • NG_017006.1:g.865C>A
  • NM_000059.3:c.-39-332G>T
Links:
dbSNP: rs9567552
NCBI 1000 Genomes Browser:
rs9567552
Molecular consequence:
  • NM_000059.4:c.-39-332G>T - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Breast-ovarian cancer, familial, susceptibility to, 2 (BROVCA2)
Synonyms:
Breast-ovarian cancer, familial 2
Identifiers:
MONDO: MONDO:0012933; MedGen: C2675520; Orphanet: 145; OMIM: 612555

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000244916Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)
reviewed by expert panel

(ENIGMA BRCA1/2 Classification Criteria (2015))		Benign
(Jan 12, 2015) 		germlinecuration

ENIGMA BRCA1/2 Classification Criteria (2015)

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedcuration

Details of each submission

From Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA), SCV000244916.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3374 (Asian), 0.128 (African), 0.2124 (European), derived from 1000 genomes (2012-04-30).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 1, 2024